Viatris closes divestitures of OTC business
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Achievement of This Major Milestone Further Simplifies and Strengthens the Company and Positions Viatris to Achieve its Key Priorities and Accelerate Future Growth
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Transaction is non-dilutive, with 100% performance-based payment through a royalty model
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The Profit After Tax (PAT) for Q4 FY24 at Rs 36.40 crore, compared to Rs 38.23 crore in Q4 FY23
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Cresset’s new India site will support the growing demands of Cresset’s APAC customer base
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Subscribe To Our Newsletter & Stay Updated